In Vivo Modulation of FGF Biological Activity Alters Cranial Suture Fate-Reference-Cited by-同舟云学术

In Vivo Modulation of FGF Biological Activity Alters Cranial Suture Fate

Published:2001-02 Issue:2 Volume:158 Page:441-452
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Greenwald Joshua A.,Mehrara Babak J.,Spector Jason A.,Warren Stephen M.,Fagenholz Peter J.,Smith Lee P.,Bouletreau Pierre J.,Crisera Francesca E.,Ueno Hikaru,Longaker Michael T.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference45 articles.

1. Craniosynostosis: genes and mechanisms;Wilkie;Hum Mol Genet,1997

2. Mutation associated with Crouzon syndrome causes ligand-independent dimerization and activation of FGF receptor-2;Mangasarian;J Cell Physiol,1997

3. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras;Galvin;Proc Natl Acad Sci USA,1996

4. Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains;Neilson;J Biol Chem,1996

5. Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome;Neilson;J Biol Chem,1995

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infigratinib, a selective FGFR1‐3 tyrosine kinase inhibitor, alters dentoalveolar development at high doses;Developmental Dynamics;2023-07-12

2. FGF signaling in cranial suture development and related diseases;Frontiers in Cell and Developmental Biology;2023-06-01

3. The clinical manifestations, molecular mechanisms and treatment of craniosynostosis;Disease Models & Mechanisms;2022-04-01

4. The Intertwined Evolution and Development of Sutures and Cranial Morphology;Frontiers in Cell and Developmental Biology;2021-03-26

5. Insights and future directions of potential genetic therapy for Apert syndrome: A systematic review;Gene Therapy;2021-02-22